Review




Structured Review

SMAC Corp soluble c5b-9 smac
TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level, <t> soluble C5b-9, </t> and FI level were all within normal limits.
Soluble C5b 9 Smac, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+c5b-9+smac/soluble+membrane+attack+complex/pmc09036209-8-0-2
Average 90 stars, based on 1 article reviews
soluble c5b-9 smac - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy"

Article Title: Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy

Journal: Hematology Reports

doi: 10.3390/hematolrep14020018

TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level,  soluble C5b-9,  and FI level were all within normal limits.
Figure Legend Snippet: TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level, soluble C5b-9, and FI level were all within normal limits.

Techniques Used: Functional Assay, Biomarker Discovery, Hemolytic Assay

Related Articles

Functional Assay:


Article Title: Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19.
Article Snippet: Pre- eculizumab bloodwork revealed a low CH50 complement activity level of 3 units (normal range 60-144), with elevated Factor H, Factor I, Bb fragment level, and soluble C5b-9 (sMAC) levels (0.45 mg/L, normal <0.3).

Biomarker Discovery:


Article Title: Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19.
Article Snippet: Pre- eculizumab bloodwork revealed a low CH50 complement activity level of 3 units (normal range 60-144), with elevated Factor H, Factor I, Bb fragment level, and soluble C5b-9 (sMAC) levels (0.45 mg/L, normal <0.3).

Hemolytic Assay:


Article Title: Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19.
Article Snippet: Pre- eculizumab bloodwork revealed a low CH50 complement activity level of 3 units (normal range 60-144), with elevated Factor H, Factor I, Bb fragment level, and soluble C5b-9 (sMAC) levels (0.45 mg/L, normal <0.3).



Similar Products

90
SMAC Corp soluble c5b-9 smac
TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level, <t> soluble C5b-9, </t> and FI level were all within normal limits.
Soluble C5b 9 Smac, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+c5b-9+smac/soluble+membrane+attack+complex/pmc09036209-8-0-2
Average 90 stars, based on 1 article reviews
soluble c5b-9 smac - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
SMAC Corp soluble membrane attack complex (smac; c5b-9)
TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level, <t> soluble C5b-9, </t> and FI level were all within normal limits.
Soluble Membrane Attack Complex (Smac; C5b 9), supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/soluble+c5b-9+smac/soluble+membrane+attack+complex/pmc03338285-94-3-6
Average 90 stars, based on 1 article reviews
soluble membrane attack complex (smac; c5b-9) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level,  soluble C5b-9,  and FI level were all within normal limits.

Journal: Hematology Reports

Article Title: Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy

doi: 10.3390/hematolrep14020018

Figure Lengend Snippet: TMA functional panel results. Complement biomarker profiling revealed a low FH level, an elevated Bb factor level, and the C3 level, C4 level, FB level, soluble C5b-9, and FI level were all within normal limits.

Article Snippet: Soluble C5b-9 (sMAC) , 0.27 mg/L , <0.3 mg/L , normal.

Techniques: Functional Assay, Biomarker Discovery, Hemolytic Assay